SCHEMBL6109554

SCHEMBL6109554

COc1cc(N)ccc1C(=O)NCCCN(C)C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 4/20 0.60
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 1/20 0.50
APP P05067 2/20 0.48
POLB P06746 1/20 0.47
HPGD P15428 1/20 0.47
RAD52 P43351 1/20 0.46
UHRF1 Q96T88 1/20 0.46
CYP1A2 P05177 2/20 0.46
ADRA2A P08913 2/20 0.46
CYP2D6 P10635 2/20 0.46
DRD3 P35462 2/20 0.46
HTT P42858 2/20 0.46
HTR2A P28223 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
SLC22A1 O15245 1/20 0.46
HTR3B O95264 1/20 0.46
LMNA P02545 1/20 0.46
MPO P05164 1/20 0.46
DRD2 P14416 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6108941 0.92 MCHR1 (0.57) MCHR1ALDH1A1POLBHPGDRAD52
SCHEMBL13733997 0.85 ALDH1A1 (0.58) ALDH1A1POLBHPGDCYP1A2ADRA2A
SCHEMBL6140571 0.85 MCHR1 (0.62) MCHR1ALDH1A1KDM4EAPPPOLB
SCHEMBL11754259 0.84 KDM4E (0.54) MCHR1ALDH1A1KDM4EAPPPOLB
SCHEMBL12172265 0.83 HTT (0.62) MCHR1ALDH1A1KDM4EPOLBHPGD
SCHEMBL1185641 0.82 LMNA (0.67) MCHR1ALDH1A1CYP1A2ADRA2ACYP2D6
SCHEMBL14094442 0.82 SIGMAR1 (0.55) ALDH1A1KDM4EPOLBHPGDCYP1A2
SCHEMBL3762394 0.81 ALDH1A1 (0.54) MCHR1ALDH1A1POLBHPGDCYP1A2
SCHEMBL3760672 0.81 ALDH1A1 (0.50) MCHR1ALDH1A1POLBHPGDCYP1A2
Dimethylamine SCHEMBL6109558 0.80 ALDH1A1 (0.64) ALDH1A1POLBHPGDCYP1A2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235035-A1 Novel methoxybenzamibe compounds for use in mch receptor related disorders 7TM PHARMA A/S (DK) 2006-10-19 US disclosed
EP-1497260-A1 NOVEL METHOXYBENZAMIDE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS 7TM Pharma A/S (DK) 2005-01-19 EP disclosed
WO-2003087045-A1 NOVEL METHOXYBENZAMIDE COMPOUNDS FOR USE IN MCH RECEPTOR RELATED DISORDERS 7TM PHARMA A/S (DK) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235035-A1 Novel methoxybenzamibe compounds for use in mch receptor related disorders GPR119, MCHR2, HCRTR2 MCHR1 5/4885ALDH1A1 3618/4885KDM4E 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.